Temozolomide for the Treatment of Brain Metastases Associated With Metastatic Melanoma: A Phase II Study

2004358 citationsJournal Article

Authors

Sanjiv S. Agarwala · National Health Service

John M. Kirkwood · Hospital Sírio-Libanês

Martin Gore · National Health Service

Brigitte Dréno · Hospital Sírio-Libanês

Nicholas Thatcher · Hospital Sírio-Libanês

Beate Czarnetski · Hospital Sírio-Libanês

Michael B. Atkins ·

Abstract

Temozolomide was well tolerated and demonstrated activity in the treatment of brain metastases from MM. Further evaluation of temozolomide combination therapy is warranted.

Topics & Keywords

Brain Metastases and Treatment Lung Cancer Treatments and Mutations Lung Cancer Research Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 22, Issue 11, pp. 2101-2107

DOI: 10.1200/jco.2004.11.044

Field-Weighted Citation Impact: 18.15